In this expert discussion, Josh Ludwig (ScaleReady), Carol Houts (Germfree), Heather Purvis (Title21), and Priya Baraniak (Pluristyx) explore the urgent need for clinical readiness in cell and gene therapy delivery.

Our panelists discuss the key challenges faced by clinical centers, the importance of standardization, and how industry collaboration can accelerate patient access. By addressing these barriers, we can support the seamless integration of cell and gene therapies into healthcare systems and ensure that life-saving therapies reach patients faster.

Watch this insightful discussion to learn how the industry is working to advance clinical readiness and overcome obstacles to widespread CGT adoption.